ANNELISE MILLAN: Open Payments
NPI 1275351066 · CATHEDRAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$78 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $78
Food & beverage: $78
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Viatris Specialty LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Kerendia, XIFAXAN, YUPELRI, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
